Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Continuation in Non-cardiac Surgery
NCT04284722Phase 4Unknown
- Sponsor
- Kepler Universitätsklinikum
- Start
- Feb 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Kepler Universitätsklinikum. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04284722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04284722.